İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

HASAN AKBABA

DOÇENT

EGE ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK TEKNOLOJİSİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Biyoteknoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 45
  • Proje 0
  • Kitap 10
  • Bildiri 23
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 20 Q2 10 Q3 8 Q4 0
WoS (JCR) Q1 14 Q2 12 Q3 3 Q4 6
TR Index 12 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 11
Ort. yüzdelik 68.2%
Üst %1 payı 0.0%
Üst %10 payı 25.6%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 45 yayın

Scopus (SJR)
Q1 20 Q2 10 Q3 8 Q4 0
WoS (JCR)
Q1 14 Q2 12 Q3 3 Q4 6
TR Index
12 makale

Makale listesi

  1. 2025 Recombinant ROP6 protein expressed in Saccharomyces cerevisiae INVSc1 cells induced strong immune response and provided significant protection against toxoplasmosis Scientific Reports DOI 10.1038/s41598-025-14988-9 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.3%
  2. 2025 Rabies virus-mimicking liposomes for targeted gene therapy in Alzheimer’s disease International Journal of Pharmaceutics DOI 10.1016/j.ijpharm.2024.124962 YÖKSİS SJR Q1 JCR Q1 OpenAlex 79.2%
  3. 2025 Enhancing vaccine stability in transdermal microneedle platforms Drug Delivery and Translational Research DOI 10.1007/s13346-025-01854-4 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.8%
  4. 2025 Gene therapy strategies in tissue engineering: advances and applications for regenerative therapy Trends in Biotechnology DOI 10.1016/j.tibtech.2025.10.025 YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.3%
  5. 2025 Microfluidics Based Particle and Droplet Generation for Gene and Drug Delivery Approaches Journal of Biomedical Materials Research Part B: Applied Biomaterials DOI 10.1002/jbm.b.35530 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 90.5%
  6. 2025 IL-4 impairs the formation of skin-resident memory CD8+ T cells Nature Immunology DOI 10.1038/s41590-025-02207-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.5%
  7. 2024 Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production. Scientific reports DOI 10.1038/s41598-024-64690-5 YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.6%
  8. 2024 A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis Vaccine DOI 10.1016/j.vaccine.2024.06.032 YÖKSİS SJR Q1 JCR Q2 OpenAlex 90.0%
  9. 2024 Modulation of adipogenesis and lipogenesis by indomethacin and pantoprazole Toxicology in Vitro DOI 10.1016/j.tiv.2024.105895 YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.0%
  10. 2023 Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition Elsevier BV DOI 10.1016/j.ejmech.2022.115049 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 90.4%
  11. 2023 Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders American Chemical Society (ACS) DOI 10.1021/acsomega.3c07138 YÖKSİS SJR Q2 JCR Q2 OpenAlex 74.6%
  12. 2023 Molecular and Cellular Basics of Intermittent Fasting: Traditional Review Turkiye Klinikleri DOI 10.5336/pharmsci.2022-94991 YÖKSİS TR Index OpenAlex 13.5%
  13. 2022 Long-term Stability of Cationic Phytosphingosine Nanoemulsions as Delivery Systems for plasmid DNA Celal Bayar University Journal of Science DOI 10.18466/cbayarfbe.948114 YÖKSİS TR Index OpenAlex 42.2%
  14. 2022 Atezolizumab-Conjugated Poly(lactic acid)/Poly(vinyl alcohol) Nanoparticles as Pharmaceutical Part Candidates for Radiopharmaceuticals ACS Omega DOI 10.1021/acsomega.2c05834 YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.0%
  15. 2022 Design and evaluation of erucic acid-phytosphingosine structured cationic nanoemulsions as a plasmid DNA delivery system against breast cancer cells Pharmaceutical Development and Technology DOI 10.1080/10837450.2021.2025247 YÖKSİS SJR Q2 JCR Q2 OpenAlex 49.2%
  16. 2022 Octaarginine functionalized nanoencapsulated system: In vitro and in vivo evaluation of bFGF loaded formulation for wound healing Journal of Drug Delivery Science and Technology DOI 10.1016/j.jddst.2022.103343 YÖKSİS SJR Q1 JCR Q1 OpenAlex 79.8%
  17. 2022 Development and validation of UV/VIS spectroscopy method for determination of atezolizumab in pharmaceutical products Experimental Biomedical Research DOI 10.30714/j-ebr.2022275813 YÖKSİS TR Index OpenAlex 1.6%
  18. 2021 Recruitment of solid lipid nanoparticles for the delivery of CRISPR/Cas9: primary evaluation of anticancer gene editing Nanomedicine DOI 10.2217/nnm-2020-0412 YÖKSİS SJR Q1 JCR Q1 OpenAlex 63.2%
  19. 2021 Investigation of the potential therapeutic effect of cationic lipoplex mediated fibroblast growth factor-2 encoding plasmid DNA delivery on wound healing DARU Journal of Pharmaceutical Sciences DOI 10.1007/s40199-021-00410-y YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.7%
  20. 2021 Optimization and screening of solid lipid nanoparticle production for gene delivery by factorial design and response surface methodology Experimental Biomedical Research DOI 10.30714/j-ebr.2021165779 YÖKSİS TR Index OpenAlex 43.2%

Akademisyenlere dön